메뉴 건너뛰기




Volumn 16, Issue 11, 2007, Pages 2262-2268

Oral contraceptive use and risk of breast carcinoma in situ

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

EID: 38849115624     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0456     Document Type: Article
Times cited : (22)

References (22)
  • 1
    • 0027392897 scopus 로고
    • Epidemiology of breast cancer. Findings from the Nurses' Health Study
    • Colditz GA. Epidemiology of breast cancer. Findings from the Nurses' Health Study. Cancer 1993;71:1480-9.
    • (1993) Cancer , vol.71 , pp. 1480-1489
    • Colditz, G.A.1
  • 3
    • 0035814452 scopus 로고    scopus 로고
    • Breast carcinoma in situ: Risk factors and screening patterns
    • Claus EB, Stowe M, Carter D. Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst 2001;93:1811-7.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 1811-1817
    • Claus, E.B.1    Stowe, M.2    Carter, D.3
  • 4
    • 0242390079 scopus 로고    scopus 로고
    • Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
    • (1996) Lancet , vol.347 , pp. 1713-1727
  • 5
    • 0037182768 scopus 로고    scopus 로고
    • Oral contraceptives and the risk of breast cancer
    • Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002;346:2025-32.
    • (2002) N Engl J Med , vol.346 , pp. 2025-2032
    • Marchbanks, P.A.1    McDonald, J.A.2    Wilson, H.G.3
  • 6
    • 0030843969 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
    • (1997) Lancet , vol.350 , pp. 1047-1059
  • 7
    • 38849192096 scopus 로고    scopus 로고
    • Cancer facts & figures 2007. Atlanta: American Cancer Society; 2007.
    • Cancer facts & figures 2007. Atlanta: American Cancer Society; 2007.
  • 8
    • 0034630285 scopus 로고    scopus 로고
    • Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program
    • Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 2000;160:953-8.
    • (2000) Arch Intern Med , vol.160 , pp. 953-958
    • Ernster, V.L.1    Barclay, J.2    Kerlikowske, K.3    Wilkie, H.4    Ballard-Barbash, R.5
  • 11
    • 0000154003 scopus 로고
    • Statistical methods in cancer research
    • 32. Lyon: IARC Scientific Publication;
    • Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies., 32. Lyon: IARC Scientific Publication; 1980.
    • (1980) The analysis of case-control studies , vol.1
    • Breslow, N.E.1    Day, N.E.2
  • 12
    • 0029066091 scopus 로고
    • Oral contraceptives and breast cancer risk among younger women
    • Brinton LA, Daling JR, Liff JM, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87:827-35.
    • (1995) J Natl Cancer Inst , vol.87 , pp. 827-835
    • Brinton, L.A.1    Daling, J.R.2    Liff, J.M.3
  • 13
    • 0141639766 scopus 로고    scopus 로고
    • Oral contraceptives and the risk of ductal breast carcinoma in situ
    • Claus EB, Stowe M, Carter D. Oral contraceptives and the risk of ductal breast carcinoma in situ. Breast Cancer Res Treat 2003;81:129-36.
    • (2003) Breast Cancer Res Treat , vol.81 , pp. 129-136
    • Claus, E.B.1    Stowe, M.2    Carter, D.3
  • 14
    • 33749125865 scopus 로고    scopus 로고
    • Oral contraceptive use and risk of breast carcinoma in situ (United States)
    • Gill JK, Press MF, Patel AV, Bernstein L. Oral contraceptive use and risk of breast carcinoma in situ (United States). Cancer Causes Control 2006;17:1155-62.
    • (2006) Cancer Causes Control , vol.17 , pp. 1155-1162
    • Gill, J.K.1    Press, M.F.2    Patel, A.V.3    Bernstein, L.4
  • 15
    • 0023275138 scopus 로고
    • Oral contraceptives in the United States: Trends in content and potency
    • Piper JM, Kennedy DL. Oral contraceptives in the United States: trends in content and potency. Int J Epidemiol 1987;16:215-21.
    • (1987) Int J Epidemiol , vol.16 , pp. 215-221
    • Piper, J.M.1    Kennedy, D.L.2
  • 16
    • 0031032674 scopus 로고    scopus 로고
    • A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer
    • Martinez ME, Grodstein F, Giovannucci E, et al. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997;6:1-5.
    • (1997) Cancer Epidemiol Biomarkers Prev , vol.6 , pp. 1-5
    • Martinez, M.E.1    Grodstein, F.2    Giovannucci, E.3
  • 17
    • 0032966219 scopus 로고    scopus 로고
    • Introduction of the pill and its impact
    • Tyrer L. Introduction of the pill and its impact. Contraception 1999;59:11-6S.
    • (1999) Contraception , vol.59
    • Tyrer, L.1
  • 18
    • 0034255545 scopus 로고    scopus 로고
    • Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions
    • Ness RB, Grisso JA, Klapper J, et al. Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions. Am J Epidemiol 2000;152:233-41.
    • (2000) Am J Epidemiol , vol.152 , pp. 233-241
    • Ness, R.B.1    Grisso, J.A.2    Klapper, J.3
  • 19
    • 0036738435 scopus 로고    scopus 로고
    • Reproductive hormones and cancer: Ovarian and colon cancer
    • Burkman RT. Reproductive hormones and cancer: ovarian and colon cancer. Obstet Gynecol Clin North Am 2002;29:527-40.
    • (2002) Obstet Gynecol Clin North Am , vol.29 , pp. 527-540
    • Burkman, R.T.1
  • 20
    • 33645232747 scopus 로고    scopus 로고
    • The risk of breast, endometrial and ovarian cancer in users of hormonal preparations
    • Bernstein L. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations. Basic Clin Pharmacol Toxicol 2006;98:288-96.
    • (2006) Basic Clin Pharmacol Toxicol , vol.98 , pp. 288-296
    • Bernstein, L.1
  • 21
    • 0026483203 scopus 로고
    • Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation
    • Jeng MH, Parker CJ, Jordan VC. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res 1992;52:6539-46.
    • (1992) Cancer Res , vol.52 , pp. 6539-6546
    • Jeng, M.H.1    Parker, C.J.2    Jordan, V.C.3
  • 22
    • 38849133862 scopus 로고    scopus 로고
    • Breast cancer facts & figures 2005-2006. Atlanta: American Cancer Society, Inc.
    • Breast cancer facts & figures 2005-2006. Atlanta: American Cancer Society, Inc.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.